InspireMD Valuation
| NSPR Stock | USD 2.92 0.10 3.31% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. InspireMD retains a regular Real Value of $3.34 per share. The prevalent price of the firm is $2.92. Our model calculates the value of InspireMD from evaluating the firm fundamentals such as Return On Equity of -0.67, return on asset of -0.37, and Shares Outstanding of 26.08 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting InspireMD's valuation include:
Price Book 1.8419 | Enterprise Value 37 M | Enterprise Value Ebitda 0.5151 | Price Sales 11.1662 | Forward PE 11.6959 |
Undervalued
Today
Please note that InspireMD's price fluctuation is relatively risky at this time. Calculation of the real value of InspireMD is based on 3 months time horizon. Increasing InspireMD's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the InspireMD stock is determined by what a typical buyer is willing to pay for full or partial control of InspireMD. Since InspireMD is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InspireMD Stock. However, InspireMD's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.92 | Real 3.34 | Target 4.35 | Hype 2.91 | Naive 3.08 |
The intrinsic value of InspireMD's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence InspireMD's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of InspireMD helps investors to forecast how InspireMD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InspireMD more accurately as focusing exclusively on InspireMD's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use InspireMD's intrinsic value based on its ongoing forecasts of InspireMD's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against InspireMD's closest peers.
InspireMD Cash |
|
InspireMD Valuation Trend
InspireMD's real value is important for investors to make better decisions and a more accurate overall view of InspireMD's financial worth over time. Using both InspireMD's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
InspireMD Revenue by Product
InspireMD Total Value Analysis
InspireMD is now projected to have valuation of 36.99 M with market capitalization of 76.16 M, debt of 1.59 M, and cash on hands of 26.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the InspireMD fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
36.99 M | 76.16 M | 1.59 M | 26.47 M |
InspireMD Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.84. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InspireMD recorded a loss per share of 0.71. The entity last dividend was issued on the 1st of April 2019. The firm had 1:15 split on the 27th of April 2021. Based on the measurements of operating efficiency obtained from InspireMD's historical financial statements, InspireMD is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.InspireMD Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. InspireMD has an asset utilization ratio of 13.02 percent. This connotes that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that InspireMD is more efficient with each dollar of assets it utilizes for everyday operations.InspireMD Ownership Allocation
InspireMD has a total of 26.08 Million outstanding shares. 30% of InspireMD outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.InspireMD Profitability Analysis
The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.12 M.About InspireMD Valuation
The stock valuation mechanism determines InspireMD's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of InspireMD based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of InspireMD. We calculate exposure to InspireMD's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InspireMD's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.8 M | 1 M | |
| Pretax Profit Margin | (3.20) | (3.36) | |
| Operating Profit Margin | (3.41) | (3.58) | |
| Net Loss | (3.21) | (3.37) | |
| Gross Profit Margin | 0.29 | 0.26 |
InspireMD Growth Indicators
Investing in growth stocks can be very risky. If the company such as InspireMD does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.3 M | |
| Forward Price Earnings | 11.6959 |
InspireMD Current Valuation Indicators
InspireMD's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final InspireMD's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as InspireMD, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use InspireMD's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes InspireMD's worth.Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.